genprowebdirectory
News
Insights
A-Lists
Topics
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Magazine
Supplement
Resources
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Subscribe
Create a Free Account
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Search
Search
Advertising
Magazine Advertising
Website Banner Advertising
eNewsletter Advertising
Webinar Sponsorship
eBook Advertising
Email Nurture Campaigns
Ad Terms and Conditions
About GEN
Contact GEN
Create a Free Account
Log In
GEN – Genetic Engineering and Biotechnology News
Mary Ann Liebert, Inc. Publishers
News
Topics
GE Healthcare, NIBRT Partner on Cell Therapy, Single-Use Bioprocessing
News
CRISPR Anticancer Tech Aids Immune System Surveillance and Attack
Natural Products
Coffee Extracts Improve Insulin Sensitivity
Neuroscience
Cannabis During Pregnancy Alters Offspring’s Brain in Rats
Topics
Sweet-Talking Slime Mollifies Pathogens
Insights
Topics
Successfully Addressing the Challenges of Glycosylation
Brexit
Top 10 European Biopharma Clusters
Topics
One-Stop-Shop Genome Editing Product Launched by Inscripta
October 2019 Vol. 39 No. 10
Better Living through Molecular Neuropharmacology
Topics
CRISPR Dx May Help Nix Disease
A-Lists
Brexit
Top 10 European Biopharma Clusters
Insights
Top 10 U.S. Biopharma Clusters
Insights
10 Takeover Targets to Watch This Fall
Insights
What the Top 10 Biopharma CEOs Are Making
Topics
Top 10 Companies Leveraging Gene Editing in 2019
Topics
All
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Topics
GE Healthcare, NIBRT Partner on Cell Therapy, Single-Use Bioprocessing
Topics
Sweet-Talking Slime Mollifies Pathogens
Topics
Five Prime Eliminates 70 Jobs in Restructuring
Topics
CRISPR-Cas13 Developed as Combination Antiviral and Diagnostic System
Magazine
All
Supplement
October 2019 Vol. 39 No. 10
Better Living through Molecular Neuropharmacology
Topics
CRISPR Dx May Help Nix Disease
Topics
Modular Bioprocessing Makes Adaptability a Snap
Topics
A Nanomedicine Technology Sampler Pack
Resources
All
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Upcoming Webinars
A Cultured Life: Innovations in Spheroid and Organoid Models
Topics
Microfluidic Diffusional Sizing: A Novel Method for Characterizing Protein Interactions
Drug Discovery
Importance of mAb Discovery and Development in Immunotherapy
eBooks
Sample Preparation for Quality Control: Solutions for Optimized Workflows and Accurate…
Subscribe
Create a Free Account
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Search
Home
Topics
Topics
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Topics
GE Healthcare, NIBRT Partner on Cell Therapy, Single-Use Bioprocessing
Topics
Sweet-Talking Slime Mollifies Pathogens
Topics
Five Prime Eliminates 70 Jobs in Restructuring
Topics
CRISPR-Cas13 Developed as Combination Antiviral and Diagnostic System
Topics
Blood Test to Diagnose Brain Cancer in Development
Topics
Valium Soothes Best If Its Target Receptor Snuggles with Auxiliary Protein
Bioprocessing
The Combination of Ubiquitous Chromatin Opening Element (UCOE®) Expression Technology with...
Topics
Schizophrenia Memory Deficits Reversed in Adult Mice
Topics
Mitochondria Shown to Regulate Brain’s CA2 Subregion, Highlighting a Potential Target...
Topics
Breast Cell Differentiation Mapped to Help Understand How Cancer Develops
Topics
Melanoma Single-Cell Transcriptional Analysis Predicts Drug Response
Topics
Novel Gene Therapy for Duchenne Muscular Dystrophy Shows Promise
Bioprocessing
Case Study: Accelerate the Time from DNA to Material
Topics
Lonza, Prevail Therapeutics Partner on Gene Therapy Manufacturing
Topics
Hornless Genome-Edited Bull Passes Trait to Offspring
Load more
Scroll Up
Please wait while you are redirected to the right page...
We use cookies to give you a better experience on genengnews.com. By continuing to use our site, you are agreeing to the use of cookies as set in our
privacy policy.
Got it!
Edit with Live CSS
![Spark Therapeutics saw its share price tumble about 30% in early-morning trading after it reported mixed preliminary data this morning from a Phase I/II trial of its hemophilia A gene therapy candidate SPK-8001. [Source: wildpixel/Getty Images]](https://www.genengnews.com/wp-content/uploads/2018/08/Dec7_2017_Getty_487489316_GeneTherapy_60019871441892139879144-324x160.jpg "Novel Gene Therapy for Duchenne Muscular Dystrophy Shows Promise")
